Considering the well-established role of inflammatory reactive astrocytes in BBB dysfunction [139, 223], it is speculated that increased NHE1 activity in reactive astrocytes in AD and VaD brains could potentially lead to vascular inflammation, contributing to BBB dysfunction associated with cognitive impairment. The gene discussed is SLC9A1; the disease is Alzheimer disease.